Germline mutations in MLH3 may increase cancer susceptibility through synergistic interactions with other MMR genes, whereas somatic mutations in MLH3 may trigger MSI independently, thereby facilitating the initiation and progression of Lynch-like EC. Here, MLH3 is linked to cancer.